CXCR inhibitor SRT3109, Purity ≥98%

Cat. No.: X23-10-ZQ516

CXCR inhibitor SRT3109, Purity ≥98%

Synonym: SRT3109; 1204707-71-0; SRT-3109; AZD5122; AZD-5122; 5KT86HK4WX; N-(2-((2,3-Difluorobenzyl)thio)-6-(((2R,3R)-3,4-dihydroxybutan-2-yl)amino)pyrimidin-4-yl)azetidine-1-sulfonamide; CXCR inhibitor

  • CAS Number: 1204707-71-0
  • Compound CID: 44602493
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SRT3109 targets the chemokine receptors CXCR, which are part of the GPCR family. It targets CXCR2.
Molecular Weight
475.53
Molecular Formula
C18H23F2N5O4S2
Targets
CXCR2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SRT3109 can be used to explore its role as an anti-inflammatory agent in treating immune-related diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.